View in EDS HTML Full Text PDF Full Text

Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".

Saved in:
Bibliographic Details
Title: Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".
Authors: Kato M; Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japan.
Source: IJU case reports [IJU Case Rep] 2024 Nov 12; Vol. 8 (1), pp. 9-10. Date of Electronic Publication: 2024 Nov 12 (Print Publication: 2025).
Publication Type: Editorial
Journal Info: Publisher: John Wiley & Sons Australia, Ltd Country of Publication: Australia NLM ID: 101764958 Publication Model: eCollection Cited Medium: Internet ISSN: 2577-171X (Electronic) Linking ISSN: 2577171X NLM ISO Abbreviation: IJU Case Rep Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39749297
AccessLevel: 2
PubType: Editorial & Opinion
PubTypeId: editorialOpinion
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Kato+M%22">Kato M</searchLink>; Department of Urology Aichi Cancer Center Hospital Nagoya Aichi Japan.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101764958%22">IJU case reports</searchLink> [IJU Case Rep] 2024 Nov 12; Vol. 8 (1), pp. 9-10. <i>Date of Electronic Publication: </i>2024 Nov 12 (<i>Print Publication: </i>2025).
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Editorial
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22John+Wiley+%26+Sons+Australia%2C+Ltd%22">John Wiley & Sons Australia, Ltd </searchLink><i>Country of Publication: </i>Australia <i>NLM ID: </i>101764958 <i>Publication Model: </i>eCollection <i>Cited Medium: </i>Internet <i>ISSN: </i>2577-171X (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%222577171X%22">2577171X </searchLink><i>NLM ISO Abbreviation: </i>IJU Case Rep <i>Subsets: </i>PubMed not MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39749297
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1002/iju5.12805
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 9
    Titles:
      – TitleFull: Editorial Comment on "Efficacy of pembrolizumab plus lenvatinib as first-line treatment for metastatic renal cell carcinoma with multiple brain metastases".
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Kato M
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 12
              M: 11
              Text: 2024 Nov 12
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2577-171X
          Numbering:
            – Type: volume
              Value: 8
            – Type: issue
              Value: 1
          Titles:
            – TitleFull: IJU case reports
              Type: main
ResultId 1